| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10769 | 2021 |
| Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ... Autophagy 4 (2), 151-175, 2008 | 2727 | 2008 |
| Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 UK Prospective Diabetes Study Group Bmj 317 (7160), 713-720, 1998 | 2345 | 1998 |
| Cellular responses to viral infection in humans: lessons from Epstein-Barr virus AD Hislop, GS Taylor, D Sauce, AB Rickinson Annu. Rev. Immunol. 25 (1), 587-617, 2007 | 949 | 2007 |
| The immunology of Epstein-Barr virus–induced disease GS Taylor, HM Long, JM Brooks, AB Rickinson, AD Hislop Annual review of immunology 33 (1), 787-821, 2015 | 575 | 2015 |
| Phase I trial of recombinant modified vaccinia ankara encoding Epstein–Barr viral tumor antigens in nasopharyngeal carcinoma patients EP Hui, GS Taylor, H Jia, BBY Ma, SL Chan, R Ho, WL Wong, S Wilson, ... Cancer research 73 (6), 1676-1688, 2013 | 208 | 2013 |
| CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1 SP Lee, JM Brooks, H Al-Jarrah, WA Thomas, TA Haigh, GS Taylor, ... The Journal of experimental medicine 199 (10), 1409-1420, 2004 | 198 | 2004 |
| A recombinant modified vaccinia ankara vaccine encoding Epstein–Barr virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer GS Taylor, H Jia, K Harrington, LW Lee, J Turner, K Ladell, DA Price, ... Clinical Cancer Research 20 (19), 5009-5022, 2014 | 188 | 2014 |
| CD4+ T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines HM Long, TA Haigh, NH Gudgeon, AM Leen, CW Tsang, J Brooks, ... Journal of virology 79 (8), 4896-4907, 2005 | 181 | 2005 |
| Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... Nature immunology 23 (1), 40-49, 2022 | 173 | 2022 |
| Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV … GS Taylor, TA Haigh, NH Gudgeon, RJ Phelps, SP Lee, NM Steven, ... Journal of virology 78 (2), 768-778, 2004 | 162 | 2004 |
| The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation AJ McCarthy, HM Kingman, C Kelly, GS Taylor, EO Caul, D Grier, ... Bone marrow transplantation 24 (12), 1315-1322, 1999 | 129 | 1999 |
| Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display CS Leung, TA Haigh, LK Mackay, AB Rickinson, GS Taylor Proceedings of the National Academy of Sciences 107 (5), 2165-2170, 2010 | 128 | 2010 |
| Immune defence against EBV and EBV-associated disease HM Long, GS Taylor, AB Rickinson Current opinion in immunology 23 (2), 258-264, 2011 | 125 | 2011 |
| The role of tetraspanin CD63 in antigen presentation via MHC class II SH Petersen, E Odintsova, TA Haigh, AB Rickinson, GS Taylor, ... European journal of immunology 41 (9), 2556-2561, 2011 | 103 | 2011 |
| Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma KC Straathof, AM Leen, EL Buza, G Taylor, MH Huls, HE Heslop, ... The Journal of Immunology 175 (6), 4137-4147, 2005 | 100 | 2005 |
| EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines TA Haigh, X Lin, H Jia, EP Hui, ATC Chan, AB Rickinson, GS Taylor The Journal of Immunology 180 (3), 1643-1654, 2008 | 99 | 2008 |
| Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence D Bakkalci, Y Jia, JR Winter, JEA Lewis, GS Taylor, HR Stagg Journal of global health 10 (1), 2020 | 95 | 2020 |
| The T-cell response to Epstein-Barr virus–new tricks from an old dog HM Long, BJ Meckiff, GS Taylor Frontiers in immunology 10, 2193, 2019 | 94 | 2019 |
| Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for Cd8+T Cell Recognition Reveals a Proteasome-Dependent, Transporter Associated … G Lautscham, S Mayrhofer, G Taylor, T Haigh, A Leese, A Rickinson, ... The Journal of experimental medicine 194 (8), 1053-1068, 2001 | 93 | 2001 |
Jill M. BrooksResearch Fellow, Cancer and Genomic Sciences, University of Birmingham在 bham.ac.uk 的电子邮件经过验证
